Tag: Bluebird bio

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Bluebird bio

Pricey new gene therapies for sickle cell pose access test | BioPharma Dive

Added to Collection on: 2023-12-08 23:10:43

Tags for this article:

Health in Africa
Hematopathology
Sickle-cell disease
Bluebird bio
Vertex Pharmaceuticals
Medicaid
Therapy

Click the tags to see associated articles and topics

View Article Details
Bluebird gene therapy, now approved for sickle cell, shows durable benefit in study update

Added to Collection on: 2023-12-09 22:07:00

Tags for this article:

Biotechnology
Hematopathology
Health in Africa
Sickle-cell disease
Hematology
Blood
Gene therapy
Hematopoietic stem cell transplantation
Complete blood count
Stem cell
Leukemia
Fetal hemoglobin
Bluebird bio

Click the tags to see associated articles and topics

View Article Details
Ide-Cel Earns European Approval in Triple-Class Exposed Multiple Myeloma

Added to Collection on: 2024-03-21 21:01:54

Tags for this article:

Orphan drugs
Idecabtagene vicleucel
Bluebird bio
Multiple myeloma
Daratumumab
Proteasome inhibitor
Pomalidomide
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
Global Cell and Gene Therapy Manufacturing Market Report - GlobeNewswire

Added to Collection on: 2024-06-14 16:16:30

Tags for this article:

Biotechnology
Gene therapy
Pharmaceutical industry
Pharmacy
Molecular biology
Cell therapy
Biopharmaceutical
Catalent
CAR T cell
Novartis
Bluebird bio
Medication

Click the tags to see associated articles and topics

View Article Details
bluebird bio (NASDAQ:BLUE) Rating Lowered to Neutral at JPMorgan Chase & Co.

Added to Collection on: 2024-08-16 03:43:54

Tags for this article:

Orphan drugs
Equity securities
Bluebird bio
Stock market
Elivaldogene autotemcel
Betibeglogene autotemcel
Berkshire Hathaway
Stock
Michael Burry
Meta Platforms
NASDAQ
Hedge fund
Bluebird Bio Inc

Click the tags to see associated articles and topics

View Article Details
Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) PT at $5.46 - Defense World

Added to Collection on: 2024-08-18 17:26:13

Tags for this article:

Orphan drugs
Biotechnology
Gene delivery
Stock market
Bluebird bio
Equity securities
Elivaldogene autotemcel
Betibeglogene autotemcel
Overweight
Short
Gene therapy
Share

Click the tags to see associated articles and topics

View Article Details
Short Interest in bluebird bio, Inc. (NASDAQ:BLUE) Grows By 20.0% - MarketBeat

Added to Collection on: 2024-09-15 22:19:33

Tags for this article:

Stock market
Bluebird bio
Dividend
Short
Stock
Bluebird Bio Inc

Click the tags to see associated articles and topics

View Article Details
Around the Helix: Cell and Gene Therapy Company Updates – September 25, 2024

Added to Collection on: 2024-09-25 19:30:34

Tags for this article:

Biotechnology
Stem cells
Food and Drug Administration
Pharmaceuticals policy
Pharmacy
Regenerative Medicine Advanced Therapy
Gene therapy
Cell therapy
Therapy
CAR T cell
Fabry disease
Bluebird bio

Click the tags to see associated articles and topics

View Article Details
Gene Therapy Shows Long-Term Benefit for Patients with a Rare Pediatric Brain Disease

Added to Collection on: 2024-10-09 21:50:03

Tags for this article:

Gene delivery
Rare diseases
Applied genetics
Molecular genetics
Orphan drugs
Elivaldogene autotemcel
Bluebird bio
Gene therapy
Adrenoleukodystrophy
Lentiviral vector in gene therapy
Leukodystrophy
Viral vector

Click the tags to see associated articles and topics

View Article Details
Be Biopharma Appoints Susan Abu-Absi, Ph.D. as Chief Operating Officer | citybiz

Added to Collection on: 2025-03-03 18:15:36

Tags for this article:

Biotechnology
Pharmacy
Biopharmaceutical
Pharmaceutical industry
Bristol-Myers Squibb
Gene therapy
Bluebird bio

Click the tags to see associated articles and topics

View Article Details
Book a Demo